Clinical Trial Update: Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated neoadjuvant cisplatin and gemcitabine with sunitinib before radical cystectomy for bladder cancer and was terminated; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)
• Sutent (sunitinib)

Snippet

Sponsor: Noah Hahn, M.D. | Conditions: Transitional Cell Carcinoma of the Bladder | Phase 2 | Status: TERMINATED | Results posted: 2016-04-14